World leaders in the field of diagnostics will assemble at Dublin City University next week to participate in the launch of the Biomedical Diagnostics Institute by the Taoiseach Bertie Ahern (Irish Prime Minister).
The agenda for the event will include internationally-renowned speakers including Professor Adam Heller, founder of diagnostics giant Therasense. The event will also include a panel discussion entitled “Who Will Monitor Your Health?” on the controversial topic of access to personal health information by third parties such as health insurance companies.
The development of sophisticated diagnostic technologies means that more information will be available to our doctors than ever before. The health benefits offered by these advances are clear, but there are other potential uses for this information that have broader societal implications. For example, could your health insurance policy be linked to your compliance with a healthcare regime, monitored by diagnostic tests? The panel will include Oliver Tattan, CEO and founder of Vivas Health, Gerry McQuaid, Commercial Director of O2 Mobile Communications, and Dr. Karina Halley, Lecturer in Ethics at TCD.
Professor Heller’s talk will focus on the founding of Therasense, a company which developed blood glucose monitoring technology for diabetes management, based on discoveries made in his lab at the University of Texas. TheraSense was acquired in 2004 by Abbott Laboratories for $1.25 billion, the largest acquisition ever in biosensors. TheraSense based sales of Abbott in 2005 exceeded $500 million and the company employs 1,500 people worldwide.
The Biomedical Diagnostics Institute
The Biomedical Diagnostics Institute (BDI) is a unique industrial-clinical-academic research collaboration focused on the development of next generation biomedical diagnostic devices for use in the home or at the Point-of-Care. These advanced devices will enable the detection of life-threatening events long before the critical stage is reached - thus improving people’s lives and enhancing the efficiency of our healthcare system. Research is being carried out to exploit “markers” in blood, breath and saliva that will give these early warnings in illnesses like cancer, heart disease and diabetes, with “exquisite accuracy” according to Professor Brian MacCraith, Director of the Institute.
The integration of fundamental and applied research, from the wide-ranging scientific and engineering disciplines required, into working device demonstrators is a unique feature of the BDI. The BDI brings together key academic researchers, led and hosted by Dublin City University, including the Royal College Surgeons Ireland, National University Ireland Galway and University College Cork; six industrial partners, Åmic, Analog Devices, Becton Dickinson, Enfer Scientific, Hospira, and Inverness Medical Innovations/Unipath, as well as the clinical environment, to form an integrated, cohesive, multi-disciplinary team of more than 70 people.
Shane Kenny | alfa
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
24.10.2016 | Universität Basel
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Power and Electrical Engineering
24.10.2016 | Life Sciences
24.10.2016 | Life Sciences